• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

59 岁女性侵袭性肝细胞癌-胆管细胞癌混合型罕见尸检病例报告

A Rare Autopsy Case of Aggressive Combined Hepatocellular-Cholangiocarcinoma in 59-Year-Old Female.

机构信息

Department of Pathology, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, USA

Department of Pathology, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, USA.

出版信息

Ann Clin Lab Sci. 2024 Jan;54(1):106-111.

PMID:38514067
Abstract

Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a liver tumor with features of both hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). It consists of intermingled malignant biliary and hepatic tissue and thus a distinct entity, rather than two separate coexisting malignancies. A 59-year-old female with a history of hepatitis C and cirrhosis presented with abdominal pain and altered mental status. She developed hematemesis, and despite extensive interventions, she expired one day after her initial presentation. At autopsy, the liver was diffusely and markedly fibrotic with numerous nodules of varying size with invasion into adjacent vasculature. Microscopic examination of the nodules revealed cHCC-CC with stem cell features, lymphovascular invasion, and tumor emboli scattered throughout the right lung. The patient had end-stage liver disease due to the accumulation of damage and consequent fibrosis. This led to portal hypertension with subsequent massive gastrointestinal bleeding, hemorrhagic shock, and death. cHCC-CC is a rare, aggressive primary liver tumor with a poor prognosis. It can present with a cirrhotomemetic pattern with small nodules that can evade clinical and radiographic detection. Autopsy findings can provide valuable insights into the pathogenesis and clinical course of cHCC-CC, highlight the aggressive nature of the disease, and may inform future diagnostic and therapeutic strategies. Accurate diagnosis of this tumor is important for patient management and prognostication.

摘要

肝细胞癌-胆管细胞癌(cHCC-CC)是一种具有肝细胞癌(HCC)和肝内胆管癌(ICC)特征的肝脏肿瘤。它由混杂的恶性胆道和肝组织组成,因此是一种独特的实体,而不是两种同时存在的独立恶性肿瘤。一名 59 岁女性,有丙型肝炎和肝硬化病史,表现为腹痛和精神状态改变。她出现了呕血,尽管进行了广泛的干预,但在最初出现后的一天就去世了。尸检时,肝脏弥漫性和显著纤维化,有许多大小不一的结节,并侵犯相邻血管。结节的显微镜检查显示具有干细胞特征的 cHCC-CC,有淋巴血管侵犯,肿瘤栓子散布在整个右肺中。由于损伤和随之而来的纤维化的积累,患者患有终末期肝病。这导致门静脉高压,随后发生大量胃肠道出血、出血性休克和死亡。cHCC-CC 是一种罕见的、侵袭性的原发性肝脏肿瘤,预后不良。它可能表现为肝硬化性小结节模式,这些小结节可能会逃避临床和影像学检测。尸检结果可以深入了解 cHCC-CC 的发病机制和临床过程,突出疾病的侵袭性,并可能为未来的诊断和治疗策略提供信息。准确诊断这种肿瘤对于患者的管理和预后很重要。

相似文献

1
A Rare Autopsy Case of Aggressive Combined Hepatocellular-Cholangiocarcinoma in 59-Year-Old Female.59 岁女性侵袭性肝细胞癌-胆管细胞癌混合型罕见尸检病例报告
Ann Clin Lab Sci. 2024 Jan;54(1):106-111.
2
CPZ: A Highly Sensitive Diagnostic Biomarker for the Differentiation Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma, Particularly in Poorly Differentiated Hepatocellular Carcinoma.CPZ:一种用于区分肝细胞癌和肝内胆管癌的高敏诊断生物标志物,尤其适用于低分化肝细胞癌。
Am J Surg Pathol. 2025 Jul 1;49(7):711-729. doi: 10.1097/PAS.0000000000002393. Epub 2025 Apr 7.
3
Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma.肝内胆管癌:272例患者的报告并与5829例肝细胞癌患者对比。
J Cancer Res Clin Oncol. 2009 Aug;135(8):1073-80. doi: 10.1007/s00432-009-0547-y. Epub 2009 Mar 18.
4
Liver transplantation for hepatic tumors: a systematic review.肝脏肿瘤的肝移植:一项系统综述。
World J Gastroenterol. 2014 May 14;20(18):5345-52. doi: 10.3748/wjg.v20.i18.5345.
5
Intrahepatic cholangiocarcinoma developing from biliary hamartomas: A case report and literature review.起源于胆管错构瘤的肝内胆管癌:1例报告及文献复习
Int J Surg Case Rep. 2025 Aug;133:111524. doi: 10.1016/j.ijscr.2025.111524. Epub 2025 Jun 16.
6
Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.肝细胞癌合并胆管细胞癌:临床特征、治疗方式和预后。
Ann Surg Oncol. 2012 Sep;19(9):2869-76. doi: 10.1245/s10434-012-2328-0. Epub 2012 Mar 27.
7
The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.肝细胞癌合并胆管细胞癌、肝细胞癌和肝内胆管细胞癌术后的临床特征和预后因素:倾向评分匹配分析。
Int J Med Sci. 2021 Jan 1;18(1):187-198. doi: 10.7150/ijms.50883. eCollection 2021.
8
Methylation aberrations and genomic instability synergistically drive the evolution of intrahepatic cholangiocarcinoma.甲基化异常与基因组不稳定性协同驱动肝内胆管癌的进展。
Epigenomics. 2025 Jul;17(10):661-674. doi: 10.1080/17501911.2025.2518919. Epub 2025 Jun 17.
9
Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease.超声检查在酒精性肝病患者中对酒精性肝硬化的诊断作用
Cochrane Database Syst Rev. 2016 Mar 2;3(3):CD011602. doi: 10.1002/14651858.CD011602.pub2.
10
Impact of hepatocellular carcinoma-related prognostic factors on combined hepatocellular cholangiocarcinoma: A surgical cohort study.肝细胞癌相关预后因素对肝内胆管癌的影响:一项外科队列研究。
Eur J Surg Oncol. 2025 Jun 24;51(9):110279. doi: 10.1016/j.ejso.2025.110279.